Physician profile
Andrew Casden
NPI 1730168410
$6,882.92
in general payments reported to CMS, 2019-2025
13 companies · $2,290 in 2025
The $2,290 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,264 · 2020: $169 · 2021: $318 · 2022: $645 · 2023: $355 · 2024: $1,842 · 2025: $2,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,041 · Food and Beverage: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,041.45 |
| Food and Beverage | $1,445.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,561.67 | 2019-2025 | Everest Spinal System, Yukon Oct Spinal System, Axsos |
| Vb Spine LLC | $1,893.60 | 2025 | Everest Spinal System |
| Medtronic USA, INC. | $668.53 | 2019-2020 | |
| Arteriocyte Medical Systems, INC. | $266.60 | 2024 | Magellan |
| Nuvasive, INC. | $128.10 | 2019 | |
| Gotham Surgical Solutions & Devices, INC. | $120.21 | 2025 | |
| Bioventus LLC | $69.86 | 2024 | Exogen Ultrasound Bone Healing System, Bonescalpel & Sonicone (O.R.) |
| Alphatec Spine, INC | $38.10 | 2024 | |
| Medtronic, INC. | $36.66 | 2024 | Mazor X System |
| Si-Bone, INC. | $36.23 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.84 | 2021 | |
| Merck Sharp & Dohme LLC | $21.36 | 2023 | Bridion |
| Davol INC. | $20.16 | 2024 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Casden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.